Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM
| Date | 7th, Aug 2020 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.